2026/06/22 by Clara Gallay, Natalia Soldevila‐Domenech, David López‐Martos +9 · 1 voice
Medicine · Neuroscience · #Cancer-related cognitive impairment studies #Menopause: Health Impacts and Treatments #Stress Responses and Cortisol
paper · doi:10.1212/wnl.0000000000218153
openalex publication_date 2026/06/22 · openalex created_date 2026/06/23 · openalex updated_date 2026/07/27
BACKGROUND AND OBJECTIVES: Epidemiologic studies exploring the effect of parity on Alzheimer disease (AD) yield mixed results, and little is known about how parity may modify the impact of AD pathology on brain and cognitive aging. We examined the effect of parity and AD pathology on hippocampal volume (HV) and cognitive changes in cognitively unimpaired (CU) postmenopausal women. METHODS: -ε4 status, age, and total intracranial volume were included as covariates. RESULTS: = 0.036). DISCUSSION: In CU postmenopausal women, higher parity interacts with AD pathology to influence cognitive decline and HV reductions. These findings suggest that parity may affect resilience to AD pathology in preclinical AD stages.